This year’s #OctoberIs4Livers, Global Liver Institute’s (GLI) liver cancer education and awareness campaign, kicked off with a special edition of GLI LIVE featuring Norman "Ned" Sharpless, MD, director of the National Cancer Institute (NCI). You can watch the interview from October 1 on YouTube and Facebook for a robust and thoughtful discussion about the global threat of liver cancer and how both GLI and the NCI are working to address this deadly disease. Sharpless joins a long list of well-regarded experts who have spoken with Donna Cryer, JD, GLI’s founder, president, and CEO.
The GLI LIVE episode with Sharpless was the first #OctoberIs4Livers activity in a series of engaging and informative global activities taking place throughout the month of October to raise awareness about liver cancer and address the many disparities that exist with this disease.
Each week the campaign focuses on a different topic in the liver cancer journey. Visit our website to learn more about our many exciting activities including the daily liver cancer word of the day, a virtual liver cancer tumor board discussion, informative social media posts, and the launch of the first State of Liver Cancer Report.
Here are 4 effective and easy ways you can spread awareness, be engaged, and do your part to improve the lives of those impacted by liver cancer.
Liver cancer is a global health threat and one of the few cancer types with increasing incidence and mortality rates. The World Health Organization’s International Agency for Research on Cancer reported an estimated 905,677 new cases and 830,180 deaths from liver cancer in 2020. Liver cancer is the third most common cause of cancer death in the world. In the United States, the American Cancer Society estimates more than 42,000 new cases of and more than 30,000 deaths from liver cancer in 2021. In the United States, the 5-year survival rate was 20% for 2010 to 2016 (American Cancer Society), an increase of 2% from the previous reporting period—but this rate is much too low.
Liver cancer disproportionately impacts most racial and ethnic groups, and there is much need to address these disparities from multiple angles. Wide disparities in liver cancer death rates by sex, race/ethnicity, and state persist, reflecting differences in the prevalence of major risk factors and, to some extent, inequalities in access to high-quality care. This #OctoberIs4Livers campaign is dedicated to creating a path to equity in liver cancers.
#OctoberIs4Livers reaches millions of people worldwide in unique ways never before accomplished for liver cancer. Too often, this highly dangerous cancer receives short shrift in public health and medical provider discussions. Patients and families suffer as a result, with late diagnoses, a dearth of helpful, practical and culturally appropriate information, and fractured treatment options, interventions and continuity of care.
Thank you for joining us during #OctoberIs4Livers.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Community Oncology Reacts to Trump's Drug Pricing Executive Order
May 2nd 2025An executive order signed on Tuesday, March 15, necessitated a change in plans for this panel discussion from the 2025 Community Oncology Conference, with the assembled experts, moderated by Ted Okon, MBA, executive director of the Community Oncology Alliance, speaking to how the order would reverberate across the community oncology space.
Read More
Advancing the Art of Medicine Through Partnership
April 29th 2025Oncology leaders from Alliance Cancer Specialists, American Oncology Network, CHI St. Vincent, Memorial Sloan Kettering Cancer Center, and New York Cancer & Blood Specialists discussed the power of collaboration in cancer care, highlighting partnerships that enhance patient outcomes and resource sharing in community practices.
Read More